(HealthDay)—Cumulative cigarette smoke exposure is an independent risk factor for hospital admission and death from COVID-19, according to a research letter published online Jan. 25 in JAMA Internal Medicine.
Katherine E. Lowe, from the Cleveland Clinic Lerner College of Medicine, and colleagues evaluated the association between cumulative smoking exposure, as measured by pack-years, and the outcomes for 7,102 patients who tested positive for COVID-19 between March 8 and Aug. 25, 2020.
The researchers found that 84.8 percent were never smokers, 2.4 percent were current smokers, and 12.8 percent were former smokers. There was a dose-response association noted between pack-years and adverse COVID-19 outcomes, with patients who smoked for more than 30 pack-years having 2.25 times higher odds of hospitalization and 1.89 times higher odds of dying following a COVID-19 diagnosis versus never smokers. The odds for all adverse outcomes were attenuated in the mediation models, in part by comorbidities. Similar odds ratios were seen for both current and former smokers.
“Smoking is imperfectly classified in patient electronic medical records, and former smokers are potentially classified as never smokers, while pack-years may be underrecorded,” the authors write. “However, this misclassification is likely to bias the present results toward the null, which would underestimate the association of cigarette smoking on adverse COVID-19 outcomes.”
Follow the latest news on the coronavirus (COVID-19) outbreak
Copyright © 2020 HealthDay. All rights reserved.
Smoking history tied to worse COVID-19 outcomes (2021, January 26)
retrieved 26 January 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022